Category

Ionis to host 2024 virtual Annual Meeting of Stockholders

CARLSBAD, Calif. , May 15, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2024 virtual Annual Meeting of Stockholders followed by a general corporate update on Thursday, June 6, 2024 .     The agenda for the event is as follows:

Ionis reports first quarter 2024 financial results

WAINUA TM  launch on track; EU and Canada approval decisions expected this year Olezarsen NDA submitted to FDA for FCS ; preparing EU regulatory submission Positive Phase 3 donidalorsen data for HAE; preparing regulatory submissions On track to achieve 2024 financial guidance CARLSBAD, Calif.

Ionis Publishes 2023 Corporate Responsibility Report

Established new corporate responsibility strategic pillars and actionable goals Received approval for two Ionis-discovered medicines in 2023, and continued to advance a broad pipeline poised to bring a steady cadence of important new medicines to people with serious diseases CARLSBAD, Calif.

You are now leaving https://www.ionis.com to visit